LADENBURG THALMANN FINANCIAL SERVICES INC. - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,0000.0%1,2500.0%0.00%
Q3 2019$5,0000.0%1,250
-7.4%
0.00%
Q2 2019$5,000
-28.6%
1,3500.0%0.00%
Q1 2019$7,000
+600.0%
1,350
+440.0%
0.00%
Q4 2018$1,000
-87.5%
250
-70.6%
0.00%
Q3 2018$8,000
-27.3%
8500.0%0.00%
Q2 2018$11,0000.0%8500.0%0.00%
Q1 2018$11,0000.0%850
+41.7%
0.00%
Q4 2017$11,000
+10.0%
600
+50.0%
0.00%
Q3 2017$10,0004000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 678,795$2,708,0006.41%
Omega Fund Management, LLC 2,600,410$10,376,0002.65%
Abingworth LLP 1,041,131$4,123,0001.58%
Arbiter Partners Capital Management LLC 2,212,844$8,830,0000.90%
Trellus Management Company, LLC 165,000$658,0000.89%
ARMISTICE CAPITAL, LLC 2,478,000$9,887,0000.62%
HIGHLAND CAPITAL MANAGEMENT LP 1,153,993$4,605,0000.27%
Bruce & Co., Inc. 266,552$1,063,0000.23%
Fortress Investment Group LLC 433,804$1,730,0000.19%
GENERAL AMERICAN INVESTORS CO INC 470,185$1,876,0000.18%
View complete list of PARATEK PHARMACEUTICALS INC shareholders